1. Home
  2. LSTA vs COCH Comparison

LSTA vs COCH Comparison

Compare LSTA & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

N/A

Current Price

$3.34

Market Cap

28.9M

Sector

Health Care

ML Signal

N/A

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

N/A

Current Price

$0.71

Market Cap

49.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LSTA
COCH
Founded
1980
1995
Country
United States
United States
Employees
N/A
47
Industry
Misc Health and Biotechnology Services
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
28.9M
49.7M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
LSTA
COCH
Price
$3.34
$0.71
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$15.00
$6.00
AVG Volume (30 Days)
59.2K
118.3K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
20.42
N/A
EPS
N/A
N/A
Revenue
$35,283,868.00
N/A
Revenue This Year
N/A
$1.58
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
56.90
N/A
52 Week Low
$1.81
$0.36
52 Week High
$5.07
$1.89

Technical Indicators

Market Signals
Indicator
LSTA
COCH
Relative Strength Index (RSI) 48.70 53.66
Support Level $3.02 $0.64
Resistance Level $3.41 $0.73
Average True Range (ATR) 0.13 0.04
MACD 0.07 0.00
Stochastic Oscillator 53.85 53.10

Price Performance

Historical Comparison
LSTA
COCH

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

Share on Social Networks: